Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal
Update: 2025-11-03
Description
Kenvue shareholders are set to receive a mix of cash and stock as part of a buyout deal with Kimberly-Clark, creating a health and hygiene giant. The deal, valued at around $21.71 per Kenvue share, combines household names like Kleenex and Scott with popular brands like Johnson's and Neutrogena. The merger, still pending shareholder approval, could reshape the market for shoppers and investors.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
